Ofloxacin Solution/ Drops
NDC Package 70069-411-01
Package Information
Ofloxacin solution/ dropses is ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below:___________________________________________________________________________CONJUNCTIVITIS:Gram-positive bacteria: Gram-negative bacteria:Staphylococcus aureus Enterobacter cloacaeStaphylococcus epidermidis Haemophilus influenzaeStreptococcus pneumoniae Proteus mirabilisPseudomonas aeruginosaCORNEAL ULCERS:Gram-positive bacteria: Gram-negative bacteria:Staphylococcus aureus Pseudomonas aeruginosaStaphylococcus epidermidis Serratiamarcescens*Streptococcus pneumoniae Anaerobic species:Propionibacterium acnes__________________________________________________________________________*Efficacy for this organism was studied in fewer than 10 infections. This formulation utilizes a solution/ drops delivery system. Marketed by Somerset Therapeutics, Llc, this product is identified by NDC 70069-411 and is authorized under FDA application ANDA213597.
Identification & Billing
- RxCUI: 312075 - ofloxacin 0.3 % Ophthalmic Solution
- RxCUI: 312075 - ofloxacin 3 MG/ML Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70069 - Somerset Therapeutics, Llc
- 70069-411 - Ofloxacin
- 70069-411-01 - 1 BOTTLE in 1 CARTON / 5 mL in 1 BOTTLE
- 70069-411 - Ofloxacin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70069-411-01 identifies a specific commercial package of 1 bottle in 1 carton / 5 ml in 1 bottle of Ofloxacin, a human prescription drug labeled by Somerset Therapeutics, Llc. This solution/ drops is formulated for ophthalmic use and contains ofloxacin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Somerset Therapeutics, Llc on October 10, 2024. The current certification is valid through December 31, 2026.
How is this Somerset Therapeutics, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70069041101. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.